Sleep Disorders Trial, Recruiting (NCT07071181)

Sleep Disorders Trial, Recruiting NCT07071181 Sponsor: Sheffield Hallam University Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT07071181 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 40 and 70 years old
People who experience poor sleep, as measured by a standard sleep quality questionnaire (a score above 5 on the Pittsburgh Sleep Quality Index)
People with a body mass index (a measure of body weight relative to height) between 25 and 35 kg/m²
People who are willing to drink a study drink every day for 4 weeks and visit the research laboratory on 4 separate occasions
Women who are taking contraception or hormone replacement therapy (HRT), provided that the medication has not been changed in the 3 months before the first study visit

Who may not be able to join:

People who have an intolerance or allergy to milk-based products
People who are pregnant or breastfeeding
People who do not have sufficient English language skills to complete the study questionnaires and cognitive tests
People who have gastrointestinal (digestive system) disorders
People who are unable to travel to the laboratory due to travel or mobility difficulties

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tony Lynn, PhD, Sheffield Hallam University

Phone: 0114 2252065

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07071181

Sponsor: Sheffield Hallam University

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: 0114 2252065

More information: https://clinicaltrials.gov/study/NCT07071181

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 40 and 70 years old
People who experience poor sleep, as measured by a standard sleep quality questionnaire (a score above 5 on the Pittsburgh Sleep Quality Index)
People with a body mass index (a measure of body weight relative to height) between 25 and 35 kg/m²
People who are willing to drink a study drink every day for 4 weeks and visit the research laboratory on 4 separate occasions
Women who are taking contraception or hormone replacement therapy (HRT), provided that the medication has not been changed in the 3 months before the first study visit

Who may not be able to join:

People who have an intolerance or allergy to milk-based products
People who are pregnant or breastfeeding
People who do not have sufficient English language skills to complete the study questionnaires and cognitive tests
People who have gastrointestinal (digestive system) disorders
People who are unable to travel to the laboratory due to travel or mobility difficulties

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Sheffield Hallam University

Registry

ClinicalTrials.gov

Start date

1 August 2025

Est. completion

1 March 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

LDL Cholesterol; Gut microbiome; Sleep quality and duration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov